Trial record 1 of 1 for:    NCT00744861
Previous Study | Return to List | Next Study

Ultrasound as Adjunct Therapy for Increasing Fusion Success After Lumbar Surgery (EXO-SPINE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00744861
Recruitment Status : Terminated (Terminated following interim analysis)
First Posted : September 1, 2008
Last Update Posted : July 24, 2013
Information provided by (Responsible Party):
Bioventus LLC

Brief Summary:
The purpose of this study is to determine whether using active low intensity pulsed ultrasound as adjunct therapy following single level posterior instrumented lumbar surgery increases the posterolateral success rate when compared to inactive (placebo) therapy.

Condition or disease Intervention/treatment Phase
Lumbar Degenerative Disc Disease Device: Low Intensity Pulsed Ultrasound Device: Sham Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 310 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: EXO-SPINE: A Prospective, Multi-center, Double-blind, Randomized, Placebo Controlled Pivotal Study of Ultrasound as Adjunctive Therapy for Increasing Posterolateral Fusion Success Following Single Level Posterior Instrumented Lumbar Surgery
Study Start Date : September 2008
Actual Primary Completion Date : May 2012
Actual Study Completion Date : June 2012

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Ultrasound

Arm Intervention/treatment
Active Comparator: Low Intensity Pulsed Ultrasound
Low Intensity Pulsed Ultrasound
Device: Low Intensity Pulsed Ultrasound
Sham Comparator: Sham
Sham (inactive) low intensity pulsed ultrasound device
Device: Sham

Primary Outcome Measures :
  1. Posterolateral fusion success at the treated level [ Time Frame: 6 months and 12 months post treatment ]

Secondary Outcome Measures :
  1. To evaluate the effect(s) of the investigational treatment on pain/disability status [ Time Frame: 12 months post treatment ]
  2. To evaluate the effect(s) of the investigational treatment on general health status [ Time Frame: 6 month and 12 month post treatment ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 81 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • The subject has a documented diagnosis of degenerative disc disease with up to Grade I spondylolisthesis at the target level
  • Requires spinal fusion of a single level disc space (L2 to S1) with the use of local bone graft.
  • Requires a posterolateral fusion procedure with or without an interbody fusion procedure using a posterior approach
  • The subject has failed non-operative treatment lasting at least 6 months.

Exclusion Criteria:

  • Requires spinal fusion at more than one lumbar level.
  • Is pregnant, is lactating or plans to become pregnant before discontinuation of study treatment

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00744861

  Hide Study Locations
United States, California
La Jolla, California, United States, 92037
Oakland, California, United States, 94609
San Francisco, California, United States, 94134
United States, Florida
Boynton Beach, Florida, United States
Clearwater, Florida, United States
United States, Georgia
Savannah, Georgia, United States, 31405
United States, Illinois
Chicago, Illinois, United States
Peoria, Illinois, United States
United States, Indiana
Indianapolis, Indiana, United States
United States, Kansas
Kansas City, Kansas, United States
Merriam, Kansas, United States
United States, Massachusetts
Boston, Massachusetts, United States
United States, Michigan
Kalamazoo, Michigan, United States, 49007
Southfield, Michigan, United States
United States, New Jersey
Egg Harbor Township, New Jersey, United States
Newark, New Jersey, United States, 07103
United States, New York
New York, New York, United States, 10016
United States, North Carolina
Charlotte, North Carolina, United States
Greenville, North Carolina, United States
United States, Oklahoma
Oklahoma City, Oklahoma, United States, 73109
United States, Pennsylvania
Philadelphia, Pennsylvania, United States, 19140
United States, Tennessee
Bristol, Tennessee, United States, 37620
United States, Texas
Houston, Texas, United States, 77043
The Woodlands, Texas, United States, 77380
United States, Utah
Salt Lake City, Utah, United States
United States, Wisconsin
Madison, Wisconsin, United States
Sponsors and Collaborators
Bioventus LLC
Principal Investigator: Jeffrey Fischgrund, MD William Beaumont Hospitals

Responsible Party: Bioventus LLC Identifier: NCT00744861     History of Changes
Other Study ID Numbers: EX-SPINE0907
First Posted: September 1, 2008    Key Record Dates
Last Update Posted: July 24, 2013
Last Verified: July 2013

Keywords provided by Bioventus LLC:
Lumbar Fusion

Additional relevant MeSH terms:
Intervertebral Disc Degeneration
Spinal Diseases
Bone Diseases
Musculoskeletal Diseases